|
Retinol Acid Pathway Modulators for Treatment of Congenital Vascular Malformation
Reference #: 01657
The University of South Carolina is offering licensing opportunities for Retinol Acid Pathway Modulators for Treatment of Congenital Vascular Malformation.
Background:
Congenital vascular malformations (CVM) are a major threat to public health with a 1.5% incident rate in the general population. Congenital capillary malformation...
Published: 12/3/2025
|
Updated: 4/24/2024
|
Inventor(s): Wenbin Tan, Vi Nguyen, J. Stuart Nelson
Keywords(s):
Category(s): Biomedical and Life Sciences
|